Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: Focus on GABA content, GABA(A) receptor α-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression

Neuroscience

Volumn 93, Issue 2, 1999, Pages 441-448

  Ohnuma, T ^a,b   Augood, S J ^b   Arai, H ^a   McKenna, P J ^c   Emson, P C ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

GABA; GABA receptor; hGAT 1; Hypofrontality; Prefrontal cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; MESSENGER RNA;

AGED; AMINO ACID ANALYSIS; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GABAERGIC TRANSMISSION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MICROPHOTOGRAPHY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGED; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PROBES; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; HUMANS; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANIC ANION TRANSPORTERS; PREFRONTAL CORTEX; RECEPTORS, GABA-A; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 0032776814     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00189-X     Document Type: Article

References (38)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archs gen. Psychiat. 52:1995;258-266.
2. Andreasen N.C. Pieces of the schizophrenia puzzle fall into place. Neuron. 16:1996;697-700.
3. Augood S.J., Faull R.L., Love D.R., Emson P.C. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience. 72:1996;1023-1036.
4. Augood S.J., Kiyama H., Faull R.L., Emson P.C. Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum. Molec. Brain Res. 9:1991;341-346.
5. Augood S.J., Kiyama H., Faull R.L., Emson P.C. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum. Neuroscience. 44:1991;35-44.
6. Augood S.J., Westmore K., Faull R.L., Emson P.C. Neuroleptics and striatal neuropeptide gene expression. Prog. Brain Res. 99:1993;181-199.
7. A receptor subunit mRNAs in chick cortical neurons. Molec. Brain Res. 26:1994;9-17.
8. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archs gen. Psychiat. 48:1991;996-1001.
9. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
10. Borden L.A., Dhar T.G., Smith K.E., Branchek T.A., Gluchowski C., Weinshank R.L. Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site. Receptors Channels. 2:1994;207-213.
11. Borden L.A., Smith K.E., Gustafson E.L., Branchek T.A., Weinshank R.L. Cloning and expression of a betaine/GABA transporter from human brain. J. Neurochem. 64:1995;977-984.
12. Bourdelais A.J., Deutch A.Y. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cerebral Cortex. 4:1994;69-77.
13. Buchsbaum M.S., DeLisi L.E., Holcomb H.H., Cappelletti J., King A.C., Johnson J., Hazlett E., Dowling-Zimmerman S., Post R.M., Morihisa J., Carpenter W., Cohen R., Pickar D., Weinberger D.R., Margolin R., Kessler R.M. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archs gen. Psychiat. 41:1984;1159-1166.
14. Buchsbaum M.S., Nuechterlein K.H., Haier R.J., Wu J., Sicotte N., Hazlett E., Asarnow R., Potkin S., Guich S. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br. J. Psychiat. 156:1990;216-227.
15. Drew K.L., O'Connor W.T., Kehr J., Ungerstedt U. Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur. J. Pharmac. 187:1990;385-397.
16. A receptor subunit messenger RNAs by increased GABA concentrations in rat brain. Neuroscience. 71:1996;661-670.
17. 3H-muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 40:1987;259-266.
18. Harrington K.A., Augood S.J., Faull R.L., McKenna P.J., Emson P.C. Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study. Molec. Brain Res. 33:1995;333-342.
19. Harrison P.J. Schizophrenia: a disorder of neurodevelopment? Curr. Opin. Neurobiol. 7:1997;285-289.
20. Ingvar D.H., Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta psychiat. scand. 50:1974;425-462.
21. Kendrick K.M., Guevara-Guzman R., de la Riva C., Christensen J., Ostergaard K., Emson P.C. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci. 8:1996;2619-2634.
22. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Molec. Brain Res. 28:1995;311-318.
23. Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog. Neuropsychopharmac. biol. Psychiat. 17:1993;887-903.
24. Morris B.J., Hunt S.P. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists. Neurosci. Lett. 125:1991;201-204.
25. Nelson H., Mandiyan S., Nelson N. Cloning of the human brain GABA transporter. Fedn Eur. biochem. Socs Lett. 269:1990;181-184.
26. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Molec. Brain Res. 56:1998;207-217.
27. Paulman R.G., Devous M.D. Sr., Gregory R.R., Herman J.H., Jennings L., Bonte F.J., Nasrallah H.A., Raese J.D. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol. Psychiat. 27:1990;377-399.
28. Qin Z.H., Weiss B. Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra. Eur. J. Pharmac. 269:1994;25-33.
29. Qin Z.H., Zhang S.P., Weiss B. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Molec. Brain Res. 21:1994;293-302.
30. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiat. 27:1990;1038-1044.
31. A receptor alpha 1 and beta 1 subunits. Fedn Eur. biochem. Socs Lett. 244:1989;361-364.
32. See R.E., Chapman M.A., Klitenick M.A. Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats. Brain Res. 588:1992;177-180.
33. Sherman A.D., Davidson A.T., Baruah S., Hegwood T.S., Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci. Lett. 121:1991;77-80.
34. Simpson M.D., Slater P., Deakin J.F., Royston M.C., Skan W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci. Lett. 107:1989;211-215.
35. Stefan M.D., Murray R.M. Schizophrenia: developmental disturbance of brain and mind? Acta paediatr. 422:(Suppl.):1997;112-116.
36. Vincent S.L., Adamec E., Sorensen I., Benes F.M. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse. 17:1994;26-35.
37. Weinberger D.R., Berman K.F. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr. Bull. 14:1988;157-168.
38. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Archs gen. Psychiat. 43:1986;114-124.